Introduction
Multidrug resistance (MDR) hampers successful chemotherapy of human cancers (reviewed in 1,2). One mechanism of MDR is closely correlated with overexpression of an Mr -170,000 plasma membrane glycoprotein termed P-glycoprotein (P-gp) (3,4). Although its exact physiological function remains unknown, MDR P-gp appears to act as an energy dependent efflux pump capable of transporting diverse anti-cancer agents out of MDR tumor cells (5.6). P-gp is the product of a small family of mammalian MDR genes. Humans have one gene, MDRl (I), whereas rodents have two genes, mdrla and mdrlb (7), which confer multidrug resistance when overexpressed in heterologous expression systems. In addition to expression in MDR tumor cells, P-gp is expressed in various normal tissues (8) . Analyses of mRNA and protein expression have shown that MDRl is highly expressed in human adrenal glands, epithelial surfaces of kidney, jejunum, and colon, and in capillary endothelial cells of the brain, whereas MDR2, which does not transport drugs, is expressed mostly in the liver (8) (9) (10) (11) (12) . In rodents, mdrla Supported JSB-1 with a 1000-fold molar excess of MAb C494 epitopespecific peptide (PNTLEGN), indicating that the epitope of MAb JSB-1 may either overlap with or be in close proximity to that of MAb C494. Immunohistochemical crossreactivity was also demonstrated in cryosections of human skeletal muscle, a tissue known not to express Pgp. MAb JSB-1 strongly immunostained Type 1 shows the highest levels of expression in endometrium, kidneys, and adrenals, mdrlb is highest in intestinal brush border, and mdr2 is highest in bile canalicular surfaces of hepatocytes (13) .
A variety of monoclonal antibodies (MAbs) to P-gp have been developed. Some of these are directed against the cytoplasmic domains of P-gp, including MAbs C219, C32, C494 (14) , and JSB-1 (15) . High-resolution epitope mapping has shown that MAb C219 recognizes a highly conserved amino acid sequence present in all isoforms of P-gp, whereas MAb C494 binds to a sequence present only in MDRl P-gp (16) . Wc have recently shown that MAb C494 crossreacts with pyruvate carboxylase (PC), and a search for epitopespecific sequences of MAb C494 revealed that mouse PC contains four of the five most reactive amino acids (REG) near the carboxy terminus (17) . Although the epitope of MAb JSB-1 has not been characterized, it is being widely used for immunohistochemical detection of P-gp in clinical tissues specimens (18, 19) . We show here that the MAb JSB-1 also crossreacts with PC under both immunoblotting and immunohistochemical conditions.
Materials and Methods
Materials. MAbs JSB-1 (lot JC25109), C494, and C219 were purchased from Signet Laboratories (Dedham, MA). Purified bovine liver PC (EC6.4.1.1), Percoll. and PBS (pH 7.4) were obtained from Sigma (St Louis, RAO, ANTHONY, PIWNICA-WORMS MO). Secondary anti-mouse antibodies were purchased from Promega (Madison. WI). For immunohistochemistry, secondary biotinylated anti-mouse antibody. alkaline phosphatase-conjugated streptavidin. and naphthol phosphatelhst Red chromogen were obtained from Biogenex (San Ramon, CA). Subcellular Fractionation. Crude liver membrane vesicles (post-nuclear fraction) from unfasted Sprague-Dawley rats (225-250 g) containing mixed canalicular and sinusoidal membranes were prepared by differential centrifugation according to the method of lshikawa et al. (20) . Rat liver mitochondria were isolated and purified on a Percoll gradient as described previously (21) . Mitochondria were subfractionated further into outer mitochondrial membrane (OM), inner mitochondrial membrane (IM). and inner membranelmatrix (IMM) fractions by the swell-shrink-sonicate procedure, followed by separation on discontinuous sucrose gradients according to the method of Hovius et al. (21) . Crude membrane and cytosolic fractions from frozen normal human skeletal muscle were prepared by a high-speed spin (100.000 x g. 1 hr). after Dounce homogenization and a low-speed spin (600 x g, 10 min) to remove debris and nuclear fragments (22) .
Western Blotting. SDS-PAGE and Western blotting were performed essentially as described in Rao et al. (17) . Briefly, membrane fractions were mixed with Laemmli sample buffer for 20 min at room temperature (RT) before they were loaded onto 7% SDS-polyacrylamide gels. After electrophoresis. gels were equilibrated in transfer buffer (0.76 M glycine, 20% methanol, 2.5 mM Tris. pH 8) and proteins were transferred to nitrocellulose sheets using a blotting apparatus (0.5 amperes at 100 V, 4°C) for 1-3 hr. Blots were blocked for 1 hr at RT in TBST and 10% bovine milk powder, followed by incubation with the primary antibody overnight at 4'C. Blots were then washed for 10 min in TBST x 3, incubated in goat anti-mouse antibody conjugated to alkaline phosphatase for 1 hr, and washed for 10 min in TBST x 3. Specific antigen-antibody complexes were revealed by incubation with 5-bromo-4-chloro-3-indolyl phosphate p-toluidine and nitroblue tetrazolium (Sigma).
Solid-phase Peptide Synthesis. A heptapeptide corresponding to the MAb C494 epitope sequence (PNTLEGN) was synthesized using Na-Fmocbased synthesis conducted on a MilligenlBiosearch 9600 synthesizer using standard (benzorriazolyloxy) Tris (dimethyl amino) phosphonium hexafluorophosphatell-hydroxybenzo triazole-coupling protocols with COOHterminal amidation Epitope-specific Reactivity. The IMM fraction and purified PC from bovine liver were electrophoresed on 7% SDS-PAGE. Immunoblotting was performed as described above with MAb JSB-1 alone and with MAb JSB-1 that had been pre-incubated for 1 hr at 4°C in distilled water containing a 1000-fold molar excess of either MAb C494 epitope-specific peptide or an irrelevant nanopeptide (human cdk2).
Immunohistochemistry. Specimens of human muscle were rapidly frozen in isopentane cooled in liquid nitrogen and sections (5-8 pm) were obtained with a Zeiss cryostat and fixed in methanol. Immunohistochemistry was performed by the same methods described previously (17) . Briefly, the primary antibody (MAb JSB-1) was incubated at 1:300 dilution (0.33 Vglml) on sections for 1-2 hr at RT. The sections were then rinsed three times with PBS and biotinylated secondary antibody was applied and incubated for 30 min, followed by three additional rinses in PBS. Alkaline phosphataseconjugated streptavidin was then applied for 30 min, rinsed three times with PBS, and naphthol phosphate substrate and Fast Red chromogen were added for approximately 10 min after preparation in Tris buffer according to the manufacturer's instructions. Sections were then rinsed in water, counterstained with hematoxylin for 30 sec, rinsed in water, dipped in ammonia, rinsed in water, and mounted with aqueous mounting medium. AIternatively, the antibody was incubated with a 10.000 molar excess of peptide sequence (PNTLEGN) overnight at 4'C.
Skeletal muscle fiber type was identified by ATPase reaction at pH 9.4 by the method of Round et al. (23) . Briefly, frozen sections (8 pm) were incubated with ATP solution (0.5 mglml ATP, 0.083 M glycine. 0.083 M NaCl buffer, 0.125 M CaC12. pH 9.4) for 40 min at 37°C. After rinsing with distilled water, sections were immersed in 2% COCIZ for 5 min. rinsed in water, and immersed in 0.2% ammonium sulfide solution (1:100 dilution of Fisher ammonium sulfide assay, 20-24%). Sections were rinsed in tapwater, dehydrated, and mounted with coverslips Muscle NADH-TR activity was also determined. Sections were cut at 8 pm thickness and air-dried for 1 min. The sections were then fixed in cold formal-calcium (1.10 CaC12. 4% formaldehyde) for 5 min and rinsed in cold deionized water. Sections were then incubated in a nitroblue tetrazo-IiumlNADH substrate solution (0.2 M Tris, 0.5 mglml nitroblue tetrazolium, 1 mglml NADH, pH 7 . 3 ) for 40 min at 37°C. After rinsing in water, sections were dehydrated through increasing concentrations of ethanol, cleared in xylene, and mounted with coverslips using permanent mounting medium.
Results
To evaluate the proteins that showed reactivity with MAbs JSB-1, C494, and C219, we performed immunoblotting of rat liver crude plasma membrane preparations. Figure 1 shows that, in crude membrane preparations, MAb C219 reacted strongly with a protein band of Mr m170,OOO corresponding to glycosylated isoforms of P-gp, whereas MAbs JSB-1 and C494 showed faint reactivity with a narrow band at M, m170,OOO. consistent with a single isoform of this protein. The strong immunoreactivity of MAb C219 would be consistent with recognition of mdr2 P-gp, highly abundant in liver canalicular membranes (24) . In addition to their faint immunoreactivity with Mr m170,OOO P-gp, MAbs JSB-1 and C494 displayed intense immunoreactivity with another protein band of Mr m130,OOO. As in a previous study with MAb C494 (17) . peptide mapping and microsequence analysis identified this Mr m130,OOO protein as PC, a mitochondrial enzyme.
Because PC is an abundant mitochondrial inner membranelmatrix-associated enzyme, we used purified rat liver mitochondrial inner membrandmatrix fractions for immunoblotting with MAb JSB-1. As shown in Figure 2 , strong immunoreactivity was observed with a protein band of Mr m130,000, corresponding to PC. Furthermore, MAb JSB-1 specifically reacted with PC purified from bovine liver (Figure 2 ). This immunoreactivity was partially abolished from both the rat mitochondrial IMM fraction and purified bovine PC when MAb JSB-1 was pre-incubated in the pres- ence of a 1000-fold molar excess of synthetic peptide containing the epitope sequence of MAb C494 (PNTLEGN). As a control, preincubation in the presence of an -1000-fold molar excess of an irrelevant nanopeptide (human cdk2 fragment) had no significant effect on the immunoreactivity of MAb JSB-1 with PC ( Figure 2 ). Partial displacement of immunoreactivity by the epitope-specific peptide suggested that the epitopes of MAb JSB-1 and MAb C494 may overlap or may be in close proximity to each other.
To directly demonstrate the relevance of crossreactivity in immunohistochemical detection of P-gp expression in normal or clinical tissue sections, we used human skeletal muscle for analysis, a tissue rich in mitochondria but lacking expression of P-gp (8.25.26). Skeletal muscle contains two fiber types; one with abundant interfibrillar and subsarcolemmal mitochondria (Type 1) and the other with few mitochondria (Type 2). Immunohistochemical staining of frozen sections of human skeletal muscle with MAb JSB-1 revealed intense immunoreactivity in a confluent particulate pattern present in Type 1 fibers only ( Figure 3A) . No plasma membrane pattern of staining was observed. However, preincubation with the MAb C494 epitope-specific synthetic heptapeptide at up to 10,000fold molar excess did not abolish immunohistochemical staining (data not shown). On serial sections, histochemical detection of ATPase and NADH activities confirmed the identity of the MAb JSB-I-crossreacting Type 1 fiber types ( Figure 3B ) and the presence of particulate mitochondrial structures in Type 2 fibers ( Figure 3C ), respectively. Because MAb C219 also crossreacts with an MI ~2 0 0 , 0 0 0 species, identified as a myosin isoform expressed only in Type 1 fibers (8), membrane and cytosolic fractions from human skeletal muscle were prepared. Western blot analysis confirmed that the crossreacting JSB-1 species was the M, ~1 3 0 , 0 0 0 PC and not the MI ~2 0 0 , 0 0 0 protein readily immunoblotted with MAb C219 on the same preparation (data not shown). Therefore, the JSB-1 immunohistochemical pattern could not be explained by crossreactivity with Type 1 myosin.
Discussion
MAbs JSB-1, C219, and C494 have been used extensively in the analysis of P-gp expression and MDR in normal and malignant tissues. These MAbs are putatively directed against three spatially distinct internal epitopes of P-gp. MAbs C219 and C494, raised against solubilized membranes from both Chinese hamster ovary and human leukemic MDR cells (14) . have had their peptide epitopes mapped. For MAb C219, epitopes are located at N-terminal positions 568-574 (VQAALD or VQVALD) and C-terminal positions 1213-1219 (VQEALD), whereas for MAb C494, the epitope is located only at C-terminal positions 1028-1035 (PNTLEGN). Because these MAbs have crossreactivities beyond MDRl P-gp, including known MAb 219 reactivity with myosin (8) and MDR2 (27), not relevant to clinical MDR, and MAb C494 crossreactivity with PC (17), caution has already been advised in the use of these reagents for detection of P-gp expression. Less is known about the epitope of MAbJSB-1. This antibody was originally raised against a colchicine-selected mutant of the Chinese hamster ovary cell line (15) and has been shown to be MDR1-specific (28). However, earlier studies on human tissues have shown that staining with MAb JSB-1 can occur in the absence of detectable MDRl mRNA expression (29).
In this study our results clearly show that the MAb JSB-1 crossreacts with PC from IMM fractions of rat liver and also with purified PC from bovine liver under immunoblotting conditions. Strong immunohistochemical staining was also seen in Type 1 fibers of human skeletal muscle. These results indicate that MAb JSB-1 crossreacts strongly with rat, bovine, and human PC. Moreover, the high intensity of immunoreactivity seen with greater dilutions of MAb JSB-1 compared to that of MAb C494, both by immunoblotting ( Figure 2 ) and immunohistochemistry ( Figure 3 ) (see also 17) . indicated that MAb JSB-1 may possess a relatively higher affinity for PC. Furthermore, partial displacement of the PC immunoreactivity under Western blotting conditions by pre-incubating MAb JSB-1 with a 1000-fold molar excess of MAb C494 epitope-specific peptide suggested that the epitope of MAb JSB-1 is similar to that of MAb C494 and may be either overlapping or in close proximity to that of MAb C494. However, Type 1 fiber immunohistochemical staining was not abolished even with a lo,ooo-fold molar excess of the same heptapeptide, shown to displace MAb JSB-1 under Western blotting conditions. This indicates either that the affinity of this heptapeptide for MAb JSB-1 is relatively low, failing to block binding of MAb JSB-1 to PC under immunohistochemical conditions, or that the epitope is conformationally dependent on assay and buffer conditions.
The robust pattern of immunoreactivity of MAb JSB-1 with Type 1 fibers of human skeletal muscle and the complete lack of immunoreactivity with Type 2 fibers was somewhat surprising. Although Type 1 fibers are rich in interfibrillar and subsarcolemmal mitochondria, consistent with the observed intense staining with The distribution of NADH staining IS particulate, with high activity in mitochondria, but also occurring in the subsarcolemmal T-tubule system (36). Type 1 fibers tend to be darker staining, although faint particulate staining is also detected in Type 2 fibers. (D) There is no significant staining when MAb JSB-1 is omitted (negative control). Bars = 100 urn.
MAb JSB-1, Type 2 fibers are also known to contain mitochondria, although fewer in number. The absence of even a weak crossreactivity with Type 2 fibers suggests that there may be isoforms of PC in skeletal muscle, with MAb JSB-1 recognizing only the form expressed in mitochondria of Type I fibers. Although two different isoforms of pyruvate carboxylase have been identified in yeast (30,31), subtypes are not yet known in humans. If shown to be true, the differential crossreactivity of MAbs JSB-1 and C494 (17) may enable investigations of putative PC isoforms. There do exist other examples of subtype-specific expression of isoforms of mitochondrial enzymes selectively expressed in the histochemical subtypes of myocytes, including, for example, type-specific isoforms of cytochrome c oxidase (32). Moreover, different forms of myosin ATPase have been recognized histochemically for some time, although it is only recently that immunohistochemistry has been used to distinguish the different isoforms in skeletal muscle (33). Interestingly, MAb C219 has also been shown to crossreact only with the myosin isoform expressed in Type 1 fibers (8).
In summary, MAb JSB-1 is known for excellent immunostaining of P-gp in formalin-fixed, paraffin-embedded, and frozen tissue sections (34), and is widely used for detection of MDRl P-gp expression in clinical specimens (18, 19, 35 ). The present study shows intense immunohistochemical staining with MAb JSB-1 in a tissue lacking expression of MDRl P-gp and has identified at least one crossreactive polypeptide as PC, an enzyme abundant in mitochondria. Caution is warranted in interpretation of Western blots or immunohistochemical sections with this MDR1-specific MAb. For diagnostic purposes, these results further demonstrate that in general it is inappropriate to conduct immunohistochemical studies utilizing only one antibody and, specifically, that molecular confirmation of MDRl P-gp may be a necessary tandem assay to exclude immunohistochemical false-positives with MAb JSB-1.
